gimli
ONESOURCE stock analysis context
ONESOURCE SPECL PHARMA L Stock Context for AI Screening
ONESOURCE SPECL PHARMA L is a small-cap stock in Healthcare. This page summarizes key screening signals for ONESOURCE SPECL PHARMA L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ONESOURCEPrice
₹1,834.50
1M return
+13.87%
3M return
+44.48%
Market cap
₹21,031.77 cr
PE
-284.94
ROE
-2.35%
RSI
61.97
Turnover
₹21.66 cr
Why it can matter in screens
- Momentum: ONESOURCE is above 50DMA, above 200DMA; RSI is 61.97.
- Returns: 1M +13.87%, 3M +44.48%, 6M +12.52%.
- Liquidity: latest turnover is ₹21.66 cr.
- Valuation: PE -284.94, PB 3.61, ROE -2.35%, ROCE +0.78%.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Try these prompts
- Analyze ONESOURCE SPECL PHARMA L with valuation, momentum and industry peers
- Compare ONESOURCE with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ONESOURCE with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.